The PAN Foundation signs MAPRx Coalition letter on the Lower Drug Costs Now Act of 2019

Setting an annual OOP limit at $2,000 would provide considerable help to beneficiaries compared with the unlimited OOP exposure under current law.

The lack of an OOP cap is one of the biggest challenges inhibiting the program from being even more successful in meeting the health care needs of Medicare beneficiaries. An annual OOP cap will help ensure Medicare beneficiaries have access to vital and life-saving medicines.